Successful Completion of Planned IDMC Review

• The seventh scheduled Independent Data Monitoring Committee (IDMC) review, evaluating the available study data for participant safety, study conduct and progress, has been successfully completed • The IDMC recommends the ACTION3 clinical trial continue unchanged, with no changes to design or safety monitoring • The IDMC has again noted no safety concerns to date, consistent with their prior revi